In this episode, we dive into the groundbreaking work of Lodestone Biomedical, a company at the forefront of cancer research innovation. Join us as we explore their Immune Response Indication System (IRIS), a revolutionary implantable biosensor that provides real-time insights into tumor dynamics. Whether you're an investor, a researcher, or someone passionate about healthcare advancements, this episode will inspire and inform. Tune in and learn how you can support the fight against cancer through Lodestone’s equity crowdfunding campaign!

Hosted on Acast. See acast.com/privacy for more information.